Treatment times in breast cancer patients receiving neoadjuvant vs adjuvant chemotherapy: Is efficiency a benefit of preoperative chemotherapy?

BACKGROUND/OBJECTIVE: Delays in times to surgery, chemotherapy, and radiotherapy impair survival in breast cancer patients. Neoadjuvant chemotherapy (NAC) confers equivalent survival to adjuvant chemotherapy (AC), but it remains unknown which approach facilitates faster initiation and completion of...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Med
Main Authors: Melchior, Nicole M., Sachs, Darren B., Gauvin, Gabrielle, Chang, Cecilia, Wang, Chihsiung E., Sigurdson, Elin R., Daly, John M., Aggon, Allison A., Hayes, Shelly B., Obeid, Elias I., Bleicher, Richard J.
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2020
Assuntos:
Clinical Cancer Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7163083/
https://ncbi.nlm.nih.gov/pubmed/32096915
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.2912
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados